Which has stronger valuation & earnings, STRR or INGN?

Star Equity has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than Star Equity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Star Equity $172.16M 0.25 -$5.92M -$2.63 N/A Inogen $348.67M 0.51 -$22.75M -$0.91 N/A

Is STRR or INGN more profitable?

Star Equity has a net margin of -4.18% compared to Inogen's net margin of -7.08%. Star Equity's return on equity of -4.04% beat Inogen's return on equity. Company Net Margins Return on Equity Return on Assets Star Equity -4.18% -4.04% -2.40% Inogen -7.08% -12.90% -8.27%

Which has stronger earnings & valuation, STRR or APYX?

Star Equity has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Star Equity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Star Equity $172.16M 0.25 -$5.92M -$2.63 N/A Apyx Medical $52.84M 3.65 -$11.21M -$0.22 N/A

Is STRR or APYX more profitable?

Star Equity has a net margin of -4.18% compared to Apyx Medical's net margin of -16.40%. Star Equity's return on equity of -4.04% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Star Equity -4.18% -4.04% -2.40% Apyx Medical -16.40% -88.47% -14.94%

Which has better valuation and earnings, STRR or HYPR?

Star Equity has higher revenue and earnings than Hyperfine. Star Equity is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Star Equity $172.16M 0.25 -$5.92M -$2.63 N/A Hyperfine $11.40M 12.19 -$35.57M -$0.41 N/A

Is STRR or HYPR more profitable?

Star Equity has a net margin of -4.18% compared to Hyperfine's net margin of -226.88%. Star Equity's return on equity of -4.04% beat Hyperfine's return on equity. Company Net Margins Return on Equity Return on Assets Star Equity -4.18% -4.04% -2.40% Hyperfine -226.88% -98.83% -67.09%

Does the media prefer STRR or HYPR?

In the previous week, Star Equity had 9 more articles in the media than Hyperfine. MarketBeat recorded 12 mentions for Star Equity and 3 mentions for Hyperfine. Star Equity's average media sentiment score of 1.39 beat Hyperfine's score of 0.91 indicating that Star Equity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Star Equity 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hyperfine 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, STRR or CVRX?

Star Equity has higher revenue and earnings than CVRx. Star Equity is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Star Equity $172.16M 0.25 -$5.92M -$2.63 N/A CVRx $56.65M 2.26 -$53.31M -$2.02 N/A

Is STRR or CVRX more profitable?

Star Equity has a net margin of -4.18% compared to CVRx's net margin of -89.14%. Star Equity's return on equity of -4.04% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets Star Equity -4.18% -4.04% -2.40% CVRx -89.14% -120.76% -48.38%

Does the media prefer STRR or CVRX?

In the previous week, Star Equity had 8 more articles in the media than CVRx. MarketBeat recorded 12 mentions for Star Equity and 4 mentions for CVRx. Star Equity's average media sentiment score of 1.39 beat CVRx's score of 0.37 indicating that Star Equity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Star Equity 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CVRx 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Star Equity (STRR) Competitors

$11.66 +0.60 (+5.42%)

Closing price 04:00 PM Eastern

Extended Trading

$11.49 -0.17 (-1.46%)

As of 04:27 PM Eastern

Compare

STRR vs. INGN, APYX, HYPR, CVRX, and SNWV

Should you buy Star Equity stock or one of its competitors? MarketBeat compares Star Equity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Star Equity include Inogen (INGN), Apyx Medical (APYX), Hyperfine (HYPR), CVRx (CVRX), and Sanuwave Health (SNWV). These companies are all part of the "medical equipment" industry.

How does Star Equity compare to Inogen?

Star Equity (NASDAQ:STRR) and Inogen (NASDAQ:INGN) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

3.8% of Star Equity shares are owned by institutional investors. Comparatively, 89.9% of Inogen shares are owned by institutional investors. 10.4% of Star Equity shares are owned by insiders. Comparatively, 2.5% of Inogen shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Star Equity has a beta of 0.49, suggesting that its stock price is 51% less volatile than the broader market. Comparatively, Inogen has a beta of 1.6, suggesting that its stock price is 60% more volatile than the broader market.

In the previous week, Star Equity had 10 more articles in the media than Inogen. MarketBeat recorded 12 mentions for Star Equity and 2 mentions for Inogen. Star Equity's average media sentiment score of 1.39 beat Inogen's score of 1.24 indicating that Star Equity is being referred to more favorably in the media.

Company	Overall Sentiment
Star Equity	Positive
Inogen	Positive

Star Equity presently has a consensus target price of $28.00, indicating a potential upside of 140.14%. Inogen has a consensus target price of $14.00, indicating a potential upside of 112.44%. Given Star Equity's higher probable upside, analysts plainly believe Star Equity is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20
Inogen	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Star Equity has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than Star Equity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Star Equity	$172.16M	0.25	-$5.92M	-$2.63	N/A
Inogen	$348.67M	0.51	-$22.75M	-$0.91	N/A

Star Equity has a net margin of -4.18% compared to Inogen's net margin of -7.08%. Star Equity's return on equity of -4.04% beat Inogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Star Equity	-4.18%	-4.04%	-2.40%
Inogen	-7.08%	-12.90%	-8.27%

Summary

Star Equity beats Inogen on 9 of the 15 factors compared between the two stocks.

How does Star Equity compare to Apyx Medical?

Star Equity (NASDAQ:STRR) and Apyx Medical (NASDAQ:APYX) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.

In the previous week, Star Equity had 11 more articles in the media than Apyx Medical. MarketBeat recorded 12 mentions for Star Equity and 1 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.89 beat Star Equity's score of 1.39 indicating that Apyx Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Star Equity	Positive
Apyx Medical	Very Positive

Star Equity has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Star Equity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Star Equity	$172.16M	0.25	-$5.92M	-$2.63	N/A
Apyx Medical	$52.84M	3.65	-$11.21M	-$0.22	N/A

Star Equity has a net margin of -4.18% compared to Apyx Medical's net margin of -16.40%. Star Equity's return on equity of -4.04% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Star Equity	-4.18%	-4.04%	-2.40%
Apyx Medical	-16.40%	-88.47%	-14.94%

Star Equity has a beta of 0.49, suggesting that its share price is 51% less volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.39, suggesting that its share price is 39% more volatile than the broader market.

3.8% of Star Equity shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 10.4% of Star Equity shares are held by company insiders. Comparatively, 15.2% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Star Equity presently has a consensus target price of $28.00, suggesting a potential upside of 140.14%. Apyx Medical has a consensus target price of $6.50, suggesting a potential upside of 41.00%. Given Star Equity's higher probable upside, equities analysts clearly believe Star Equity is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

Summary

Star Equity and Apyx Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does Star Equity compare to Hyperfine?

Star Equity (NASDAQ:STRR) and Hyperfine (NASDAQ:HYPR) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

Star Equity has higher revenue and earnings than Hyperfine. Star Equity is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Star Equity	$172.16M	0.25	-$5.92M	-$2.63	N/A
Hyperfine	$11.40M	12.19	-$35.57M	-$0.41	N/A

3.8% of Star Equity shares are held by institutional investors. Comparatively, 15.0% of Hyperfine shares are held by institutional investors. 10.4% of Star Equity shares are held by insiders. Comparatively, 26.3% of Hyperfine shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Star Equity had 9 more articles in the media than Hyperfine. MarketBeat recorded 12 mentions for Star Equity and 3 mentions for Hyperfine. Star Equity's average media sentiment score of 1.39 beat Hyperfine's score of 0.91 indicating that Star Equity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Star Equity	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hyperfine	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Star Equity presently has a consensus price target of $28.00, suggesting a potential upside of 140.14%. Hyperfine has a consensus price target of $1.78, suggesting a potential upside of 27.38%. Given Star Equity's higher probable upside, analysts plainly believe Star Equity is more favorable than Hyperfine.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20
Hyperfine	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Star Equity has a net margin of -4.18% compared to Hyperfine's net margin of -226.88%. Star Equity's return on equity of -4.04% beat Hyperfine's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Star Equity	-4.18%	-4.04%	-2.40%
Hyperfine	-226.88%	-98.83%	-67.09%

Star Equity has a beta of 0.49, meaning that its stock price is 51% less volatile than the broader market. Comparatively, Hyperfine has a beta of 1.38, meaning that its stock price is 38% more volatile than the broader market.

Summary

Star Equity beats Hyperfine on 9 of the 17 factors compared between the two stocks.

How does Star Equity compare to CVRx?

Star Equity (NASDAQ:STRR) and CVRx (NASDAQ:CVRX) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

In the previous week, Star Equity had 8 more articles in the media than CVRx. MarketBeat recorded 12 mentions for Star Equity and 4 mentions for CVRx. Star Equity's average media sentiment score of 1.39 beat CVRx's score of 0.37 indicating that Star Equity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Star Equity	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Star Equity has higher revenue and earnings than CVRx. Star Equity is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Star Equity	$172.16M	0.25	-$5.92M	-$2.63	N/A
CVRx	$56.65M	2.26	-$53.31M	-$2.02	N/A

3.8% of Star Equity shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 10.4% of Star Equity shares are held by company insiders. Comparatively, 18.9% of CVRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Star Equity has a net margin of -4.18% compared to CVRx's net margin of -89.14%. Star Equity's return on equity of -4.04% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Star Equity	-4.18%	-4.04%	-2.40%
CVRx	-89.14%	-120.76%	-48.38%

Star Equity has a beta of 0.49, indicating that its stock price is 51% less volatile than the broader market. Comparatively, CVRx has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

Star Equity currently has a consensus target price of $28.00, indicating a potential upside of 140.14%. CVRx has a consensus target price of $11.50, indicating a potential upside of 138.10%. Given Star Equity's higher possible upside, equities research analysts plainly believe Star Equity is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00

Summary

Star Equity and CVRx tied by winning 8 of the 16 factors compared between the two stocks.

How does Star Equity compare to Sanuwave Health?

Star Equity (NASDAQ:STRR) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

Sanuwave Health has a net margin of 35.96% compared to Star Equity's net margin of -4.18%. Star Equity's return on equity of -4.04% beat Sanuwave Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Star Equity	-4.18%	-4.04%	-2.40%
Sanuwave Health	35.96%	-450.56%	44.87%

Sanuwave Health has lower revenue, but higher earnings than Star Equity. Star Equity is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Star Equity	$172.16M	0.25	-$5.92M	-$2.63	N/A
Sanuwave Health	$44.05M	2.81	$11.81M	$0.33	43.58

3.8% of Star Equity shares are owned by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are owned by institutional investors. 10.4% of Star Equity shares are owned by company insiders. Comparatively, 14.4% of Sanuwave Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Star Equity has a beta of 0.49, suggesting that its stock price is 51% less volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.34, suggesting that its stock price is 34% more volatile than the broader market.

In the previous week, Star Equity had 11 more articles in the media than Sanuwave Health. MarketBeat recorded 12 mentions for Star Equity and 1 mentions for Sanuwave Health. Sanuwave Health's average media sentiment score of 1.89 beat Star Equity's score of 1.39 indicating that Sanuwave Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Star Equity	Positive
Sanuwave Health	Very Positive

Star Equity presently has a consensus price target of $28.00, suggesting a potential upside of 140.14%. Sanuwave Health has a consensus price target of $51.00, suggesting a potential upside of 254.66%. Given Sanuwave Health's stronger consensus rating and higher possible upside, analysts plainly believe Sanuwave Health is more favorable than Star Equity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Sanuwave Health beats Star Equity on 12 of the 15 factors compared between the two stocks.

Get Star Equity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STRR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

STRR vs. The Competition

Export

Metric	Star Equity	DIVERSIFIED OPS Industry	Multi-Sector Sector	NASDAQ Exchange
Market Cap	$43.14M	$18.85B	$17.31B	$11.71B
Dividend Yield	N/A	4.24%	3.99%	5.55%
P/E Ratio	-4.43	30.47	25.45	23.62
Price / Sales	0.25	9.19	7.76	105.27
Price / Cash	16.89	50.88	48.54	56.09
Price / Book	0.61	4.61	4.07	6.70
Net Income	-$5.92M	$929.92M	$920.57M	$337.26M
7 Day Performance	0.95%	-2.71%	-2.48%	-1.41%
1 Month Performance	23.26%	-3.71%	-3.50%	1.15%
1 Year Performance	455.24%	13.78%	12.50%	22.61%

Star Equity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
STRR Star Equity	4.3797 of 5 stars	$11.66 +5.4%	$28.00 +140.1%	+426.7%	$43.14M	$172.16M	N/A	1,200	Positive News Insider Trade High Trading Volume
INGN Inogen	3.1964 of 5 stars	$5.98 -1.8%	$14.00 +134.1%	-4.4%	$161.91M	$351.50M	N/A	1,030	Positive News
APYX Apyx Medical	2.5857 of 5 stars	$3.79 -1.6%	$6.50 +71.5%	+180.9%	$158.69M	$52.84M	N/A	270	Positive News
HYPR Hyperfine	3.3298 of 5 stars	$1.49 -0.7%	$1.78 +19.7%	+83.4%	$147.91M	$15.33M	N/A	190
CVRX CVRx	2.6543 of 5 stars	$5.39 -0.7%	$11.50 +113.4%	-16.5%	$143.03M	$59.07M	N/A	160	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:STRR) was last updated on 6/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Star Equity (STRR) Competitors

STRR vs. INGN, APYX, HYPR, CVRX, and SNWV

How does Star Equity compare to Inogen?

Summary

How does Star Equity compare to Apyx Medical?

Summary

How does Star Equity compare to Hyperfine?

Summary

How does Star Equity compare to CVRx?

Summary

How does Star Equity compare to Sanuwave Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STRR vs. The Competition

Star Equity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Star Equity (STRR) Competitors

STRR vs. INGN, APYX, HYPR, CVRX, and SNWV

How does Star Equity compare to Inogen?

Do institutionals & insiders have more ownership in STRR or INGN?

Which has more risk and volatility, STRR or INGN?

Does the media prefer STRR or INGN?

Do analysts recommend STRR or INGN?

Which has stronger valuation & earnings, STRR or INGN?

Is STRR or INGN more profitable?

Summary

How does Star Equity compare to Apyx Medical?

Does the media prefer STRR or APYX?

Which has stronger earnings & valuation, STRR or APYX?

Is STRR or APYX more profitable?

Which has more volatility and risk, STRR or APYX?

Do institutionals & insiders hold more shares of STRR or APYX?

Do analysts recommend STRR or APYX?

Summary

How does Star Equity compare to Hyperfine?

Which has better valuation and earnings, STRR or HYPR?

Do institutionals and insiders hold more shares of STRR or HYPR?

Does the media prefer STRR or HYPR?

Do analysts prefer STRR or HYPR?

Is STRR or HYPR more profitable?

Which has more risk and volatility, STRR or HYPR?

Summary

How does Star Equity compare to CVRx?

Does the media prefer STRR or CVRX?

Which has preferable valuation & earnings, STRR or CVRX?

Do institutionals and insiders believe in STRR or CVRX?

Is STRR or CVRX more profitable?

Which has more risk & volatility, STRR or CVRX?

Do analysts recommend STRR or CVRX?

Summary

How does Star Equity compare to Sanuwave Health?

Is STRR or SNWV more profitable?

Which has better earnings & valuation, STRR or SNWV?

Do institutionals and insiders hold more shares of STRR or SNWV?

Which has more risk and volatility, STRR or SNWV?

Does the media prefer STRR or SNWV?

Do analysts rate STRR or SNWV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STRR vs. The Competition

Star Equity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools